Development and manufacturing of pharmaceuticals, including:
injectables, parenteral solutions blood derivatives and raw
materials for the pharmaceutical industry.
Employees: 115
Overview
KAMADA LTD. is a biopharmaceutical company engaged in
Expertise
KAMADA maintains a complete line of equipment for chromatographic Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
development, production and marketing of specialty plasma
derivatives, specific and general immune globulins and other
prescribed medicines using sophisticated chromatographic
purification separation technology.
KAMADA's manufacturing facility holds latest and most advanced
equipment for production of high-quality products through
advanced technology. The fully computerized facility keeps KAMADA
at the cutting edge in maintenance of the highest standards of
quality for its products.
While operating in a surrounding that has recently become more
demanding for higher safety and quality levels, greater
availability and at the same time maintaining a relatively low
price level, KAMADA is being able to provide the necessary
solutions by delivering virally inactivated, highly pure products
sourced out of top-quality, US- FDA approved, agreement- secured
plasma sources and in same time, retain profitability which is
enabled by its efficient production process.
KAMADA's proprietary technology enables the company to produce
any required specific immunoglobulin or any other custom
developed IgG's in addition to niche products of similar nature.
This ability facilitates a variety of collaboration options based
on the company's capabilities.
Capitalizing on its advanced technology, KAMADA is producing more
than 15 different pharmaceuticals primarily for critical care
situations that arise in emergency rooms, operating theaters and
intensive care units.
The products are licensed and marketed in the local market and in
20 other countries across the globe.
The company's product line includes:
* Human plasma derivatives for intravenous or intramuscular
injection.
* Non-plasma derived drugs for injection.
* Parenteral electrolyte solutions.
purification of therapeutic proteins
